RU2607658C2 - Способ контроля антикоагулянтной терапии - Google Patents

Способ контроля антикоагулянтной терапии Download PDF

Info

Publication number
RU2607658C2
RU2607658C2 RU2013144950A RU2013144950A RU2607658C2 RU 2607658 C2 RU2607658 C2 RU 2607658C2 RU 2013144950 A RU2013144950 A RU 2013144950A RU 2013144950 A RU2013144950 A RU 2013144950A RU 2607658 C2 RU2607658 C2 RU 2607658C2
Authority
RU
Russia
Prior art keywords
plasma
coagulation
factor
factors
fiix
Prior art date
Application number
RU2013144950A
Other languages
English (en)
Russian (ru)
Other versions
RU2013144950A (ru
Inventor
Палл Торфи ОНУНДАРСОН
Бринья Р ГУДМУНДСДОТТИР
Original Assignee
Фиикс Диагностикс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фиикс Диагностикс filed Critical Фиикс Диагностикс
Publication of RU2013144950A publication Critical patent/RU2013144950A/ru
Application granted granted Critical
Publication of RU2607658C2 publication Critical patent/RU2607658C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2013144950A 2011-03-08 2012-03-08 Способ контроля антикоагулянтной терапии RU2607658C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS050010A IS2809B (is) 2011-03-08 2011-03-08 Blóðstorkumæling
IS050010 2011-03-08
PCT/IS2012/050005 WO2012120546A2 (en) 2011-03-08 2012-03-08 Method for monitoring anticoagulant therapy

Publications (2)

Publication Number Publication Date
RU2013144950A RU2013144950A (ru) 2015-04-20
RU2607658C2 true RU2607658C2 (ru) 2017-01-10

Family

ID=46682867

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013144950A RU2607658C2 (ru) 2011-03-08 2012-03-08 Способ контроля антикоагулянтной терапии

Country Status (9)

Country Link
US (2) US9234902B2 (enExample)
EP (1) EP2684056B1 (enExample)
CN (1) CN103534595B (enExample)
DK (1) DK2684056T3 (enExample)
ES (1) ES2636318T3 (enExample)
IN (1) IN2013MN01890A (enExample)
IS (1) IS2809B (enExample)
RU (1) RU2607658C2 (enExample)
WO (1) WO2012120546A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2655302C1 (ru) * 2017-05-15 2018-05-24 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования эффективности антикоагулянтной терапии у больных с фибрилляцией предсердий, перенесших инсульт
RU2660706C1 (ru) * 2017-09-26 2018-07-09 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Скрининг-тест определения контактного пути коагуляции (СТОКПК)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015154090A1 (en) * 2014-04-04 2015-10-08 Bloodworks Routine laboratory and point-of-care (poc) testing for hemostasis
US9354243B2 (en) * 2014-05-05 2016-05-31 Haemonetics Corporation Methodologies and reagents for detecting fibrinolysis and hyperfibrinolysis in a blood sample using viscoelastic analysis
SE540132C2 (sv) * 2014-05-22 2018-04-10 Zafena Ab Analysmetod för bestämning av antikoagulanter i blod eller blodplasma
WO2015191599A2 (en) 2014-06-09 2015-12-17 Terumo Bct, Inc. Lyophilization
JP6871673B2 (ja) * 2015-03-31 2021-05-12 学校法人東日本学園 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置
WO2016170944A1 (ja) * 2015-04-24 2016-10-27 公立大学法人奈良県立医科大学 血液検体の凝固能の評価方法、並びにその方法に用いるための試薬、試薬キット及び装置
WO2017119508A1 (ja) * 2016-01-07 2017-07-13 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc LYOPHILIZATION CONTAINER AND METHOD OF USE
CN109459420B (zh) * 2018-12-29 2021-06-04 华南师范大学 一种水体中二/三价铁离子的检测方法
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法
CA3153941A1 (en) * 2019-10-17 2021-04-22 Mary POMEROY Coagulation assay apparatus and methods thereof
CN114544983A (zh) * 2022-02-28 2022-05-27 南京可诺医疗技术有限公司 一种凝血与血小板功能分析仪用正常值质控品的制备方法
CN114778858A (zh) * 2022-06-23 2022-07-22 深圳市帝迈生物技术有限公司 一种狼疮抗凝物检测试剂盒
CN116840175B (zh) * 2023-07-17 2026-07-31 美迪西普胜医药科技(上海)有限公司 一种注射用重组人凝血因子ⅸ促凝特性的体外检测方法
CN122422760A (zh) * 2023-12-20 2026-07-17 彭特法姆股份公司 用于针对止血调节物分析血液样本的方法
US12405281B1 (en) 2024-03-04 2025-09-02 Fiix Diagnostics Method and kit for monitoring anticoagulant therapy
WO2025186634A1 (en) 2024-03-04 2025-09-12 Fiix Diagnostics Method and kit for monitoring anticoagulant therapy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784944A (en) * 1984-04-09 1988-11-15 Behringwerke Aktiengesellschaft Prothrombin time determining reagent and methods of using and preparing the same
EA200600893A1 (ru) * 2003-12-02 2006-12-29 Зафена Актиеболаг Определение гематокрита и концентрации аналита
US20100086953A1 (en) * 2008-10-02 2010-04-08 Siemens Healthcare Diagnostics Products Gmbh Blood Coagulation Assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123584C (enExample) * 1958-05-16
US3395210A (en) * 1964-02-07 1968-07-30 Warner Lambert Pharmaceutical Lyophilized diagnostic reagent for the determination of blood coagulation factors
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
AU2870992A (en) 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
US5447440A (en) * 1993-10-28 1995-09-05 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same
US6194394B1 (en) 1998-07-01 2001-02-27 Sigma-Aldrich Co. Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays
EP0984280A1 (en) * 1998-09-03 2000-03-08 Sysmex Corporation Anticoagulant and hemanalysis method
CN1806176A (zh) 2003-05-16 2006-07-19 国家生物标准及控制研究所 混合物
CA2539034A1 (en) * 2003-09-22 2005-03-31 Haematex Research Pty Limited Method for detecting procoagulant phospholipid
CN1952169B (zh) * 2005-10-18 2010-05-12 上海太阳生物技术有限公司 临床检验凝血酶原时间(pt)测定体外诊断试剂盒
CN101221189B (zh) * 2007-01-12 2012-08-15 上海太阳生物技术有限公司 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒
CN101526538B (zh) * 2008-03-09 2014-04-09 上海长岛生物技术有限公司 液体白陶土aptt试剂

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784944A (en) * 1984-04-09 1988-11-15 Behringwerke Aktiengesellschaft Prothrombin time determining reagent and methods of using and preparing the same
EA200600893A1 (ru) * 2003-12-02 2006-12-29 Зафена Актиеболаг Определение гематокрита и концентрации аналита
US20100086953A1 (en) * 2008-10-02 2010-04-08 Siemens Healthcare Diagnostics Products Gmbh Blood Coagulation Assays

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COSTA et al. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy. Biomed Pharmacother. 2010 Feb;64(2):130-2. Найдено в PubMed, PMID: 20045627 ();. *
COSTA et al. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy. Biomed Pharmacother. 2010 Feb;64(2):130-2. Найдено в PubMed, PMID: 20045627 (реферат);. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2655302C1 (ru) * 2017-05-15 2018-05-24 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования эффективности антикоагулянтной терапии у больных с фибрилляцией предсердий, перенесших инсульт
RU2660706C1 (ru) * 2017-09-26 2018-07-09 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Скрининг-тест определения контактного пути коагуляции (СТОКПК)

Also Published As

Publication number Publication date
WO2012120546A2 (en) 2012-09-13
EP2684056A2 (en) 2014-01-15
DK2684056T3 (en) 2017-07-10
CN103534595B (zh) 2016-03-09
IN2013MN01890A (enExample) 2015-09-25
US20160108457A1 (en) 2016-04-21
EP2684056B1 (en) 2017-05-03
US9234902B2 (en) 2016-01-12
US20120231485A1 (en) 2012-09-13
RU2013144950A (ru) 2015-04-20
WO2012120546A3 (en) 2012-11-29
IS2809B (is) 2012-10-15
ES2636318T3 (es) 2017-10-05
CN103534595A (zh) 2014-01-22

Similar Documents

Publication Publication Date Title
EP2684056B1 (en) Method for monitoring anticoagulant therapy
AU757459B2 (en) Inhibition of coagulation in blood and blood products
JP3047120B2 (ja) 活性化因子ｖｉｉに関する定量的凝血検定
Favaloro et al. The new oral anticoagulants and the future of haemostasis laboratory testing
CA2623142C (en) Methods for a global assay of coagulation and fibrinolysis
Simpson et al. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults
US20100227346A1 (en) Activation Mixture
US20110177541A1 (en) Method for adjusting the coagulation time in calibrator or control plasmas
Dong et al. Variations among normal individuals in the cleavage of endothelial‐derived ultra‐large von Willebrand factor under flow
Stief Inhibition of thrombin in plasma by heparin or arginine
CN109082458B (zh) 一种血栓弹力图法定量检测口服凝血因子Xa抑制剂试剂盒及其制备方法
Marchi et al. Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans
US12405281B1 (en) Method and kit for monitoring anticoagulant therapy
US20250355004A1 (en) Method and kit for monitoring anticoagulant therapy
Hellstern Composition of plasma
Rutmann Coagulation for the clinician
Hedner et al. Recent advances in clot biology and assessment of clotting
Zrari A modified, optimized kinetic photometric thrombin generation assay components to measure the potency of thrombin in plasma
US20080138843A1 (en) Method For Determining the Total Clotting Activity of a Blood or Plasma Sample
Wang et al. Coagulation and Fibrinolysis
JP2007505636A (ja) プロコアギュラントリン脂質の検出方法
Hellstern Composition of plasma
Lwaleed et al. An overview of haemostasis
AU2012200836A1 (en) Methods for a global assay of coagulation and fibrinolysis

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant